UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Trinity Legacy Partners LLC

Trinity Legacy Partners LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.6% during the fourth quarter, HoldingsChannel.com reports. The fund owned 10,207 shares of the healthcare conglomerate’s stock after purchasing an additional 165 shares during the quarter. UnitedHealth Group makes up about 1.3% of Trinity Legacy Partners LLC’s portfolio, making the stock its 28th biggest holding. Trinity Legacy Partners LLC’s holdings in UnitedHealth Group were worth $5,163,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Jmac Enterprises LLC lifted its position in shares of UnitedHealth Group by 2.2% during the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after purchasing an additional 18 shares in the last quarter. Wallace Capital Management Inc. grew its position in shares of UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock worth $1,239,000 after buying an additional 19 shares in the last quarter. Western Pacific Wealth Management LP raised its holdings in UnitedHealth Group by 2.2% in the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after acquiring an additional 19 shares in the last quarter. JNBA Financial Advisors grew its holdings in UnitedHealth Group by 0.4% during the 3rd quarter. JNBA Financial Advisors now owns 4,686 shares of the healthcare conglomerate’s stock worth $2,740,000 after acquiring an additional 20 shares in the last quarter. Finally, Paragon Capital Management LLC raised its stake in shares of UnitedHealth Group by 2.9% in the 3rd quarter. Paragon Capital Management LLC now owns 721 shares of the healthcare conglomerate’s stock valued at $422,000 after purchasing an additional 20 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH opened at $503.01 on Friday. The company’s fifty day moving average is $520.37 and its 200-day moving average is $561.26. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $462.91 billion, a price-to-earnings ratio of 32.45, a price-to-earnings-growth ratio of 1.40 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business posted $5.83 earnings per share. Equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have issued reports on UNH. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Piper Sandler dropped their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Truist Financial lowered their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, StockNews.com upgraded UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $629.32.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.